Cannabis Market in North Carolina

North Carolina's cannabis landscape is extremely limited. The state passed HB 1220 in 2014, which provides a narrow legal defense for patients with intractable epilepsy who use low-THC hemp extracts containing less than 0.9% THC and at least 5% CBD. This law is among the most restrictive in the nation and does not establish a functional medical cannabis program with licensing, dispensaries, or a regulated supply chain.

Efforts to establish a broader medical cannabis program have gained momentum but have not yet succeeded. The North Carolina Compassionate Care Act (SB 711) passed the state Senate in 2023 with bipartisan support, marking the first time a medical cannabis bill advanced through a chamber of the North Carolina legislature. However, the bill stalled in the House, where Republican leadership expressed concerns about the program's scope and implementation. Similar legislation continues to be debated.

North Carolina's population of over 10 million makes it the largest state without a functional medical cannabis program, representing a significant untapped market opportunity. If a medical program is eventually established, market analysts project annual sales could reach $500 million to $1 billion once mature. The state's current CBD-only framework generates minimal revenue, estimated at roughly $15 million through hemp-derived CBD products sold in retail locations. No MSOs have operations in North Carolina, though several have expressed interest in entering the market if a comprehensive medical or recreational program is enacted. The state's large population and Southeast location make it a high-priority target for MSO expansion.

The North Carolina cannabis market is regulated by the N/A — No operational licensing program, which oversees licensing, compliance, and enforcement for all cannabis businesses operating within the state. The regulatory body is responsible for issuing and renewing licenses, conducting inspections, enforcing packaging and labeling requirements, managing the seed-to-sale tracking system, and handling complaints and disciplinary actions.

The current tax structure for cannabis in North Carolina is: N/A — No operational cannabis market. Tax policy plays a critical role in determining the competitiveness of the legal cannabis market relative to the illicit market. States with excessively high tax rates often see consumers shift to unlicensed sources, while states with moderate rates tend to achieve higher legal market capture. Operators in North Carolina must also comply with comprehensive regulatory requirements including testing, labeling, advertising restrictions, and security protocols.

Investors considering exposure to the North Carolina cannabis market should evaluate several factors. The state's medical legal status, estimated market size of $15M, and limited MSO presence all influence the investment landscape. Market maturity, competitive dynamics, and regulatory stability are important considerations when evaluating companies with North Carolina operations.

Cannabis stocks carry significant risks including federal illegality, regulatory uncertainty, limited access to banking services, and high tax burdens under IRC Section 280E. State-level factors such as license availability, tax rates, and enforcement against the illicit market can materially impact the profitability of licensed operators. Investors should consider a company's overall state portfolio diversification rather than relying on exposure to any single state market. Past performance does not guarantee future results, and cannabis investments may not be suitable for all investors.